Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
365 studies found for:    "Amyotrophic lateral sclerosis"
Show Display Options
Rank Status Study
21 Unknown  Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Cistanche Total Glycosides
22 Terminated A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention:
23 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
24 Completed Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo of MCI-186
25 Not yet recruiting A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: CK-2127107;   Drug: Placebo
26 Completed Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Memantine (Ebixa);   Drug: riluzole;   Drug: Placebo
27 Unknown  Aerobic Exercise Training in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Aerobic exercise training;   Other: Standard physical therapy (Stretching/Range-of-motion)
28 Completed R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: R(+) pramipexole dihydrochloride monohydrate
29 Completed Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Olesoxime;   Drug: Placebo Comparator
30 Completed Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: TCH346
31 Completed Virtual Task in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Device: Acquisition on TouchScreen;   Device: Acquisition on Kinect;   Device: Acquisition on LeapMotion;   Device: Acquisition on TouchScreen Control Group;   Device: Acquisition on Kinect Control Group;   Device: Acquisition on LeapMotion Control Group
32 Active, not recruiting Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Genetic: VM202
33 Completed Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: Stem Cell
34 Terminated The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Behavioral: Intensive Controlled Exercise
35 Completed
Has Results
Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Ozanezumab;   Drug: Placebo
36 Completed
Has Results
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Repository corticotropin injection
37 Completed
Has Results
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo of MCI-186
38 Unknown  Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
Condition: Amyotrophic Lateral Sclerosis
Intervention:
39 Completed
Has Results
Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
Condition: Amyotrophic Lateral Sclerosis
Intervention:
40 Completed Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo of MCI-186

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.